Details for 2013168383

Up to date per 07.04.2026

Actions

Title / Product Name

Verfahren zur Behandlung von Multiplem-Myelomen mit hilfe von Kombinationstherapien auf Basis von HuLuc63 und Bortezomib

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013168383

EP Publication Number

2641601

E-Number

810206

Language

PCT Number

Publication Date

25.09.2013 A

06.07.2016 B1

Registration Date

06.07.2016

AT Publication Date

15.07.2016

Application Date

07.08.2007

Registration Number

Priorities

07.08.2006

836185 P

15.06.2007

944262 P

IPC

A61K 31/573 20060101AFI20150116BHEP

Maximum Duration of Protection

07.08.2027

Owner

AbbVie Biotherapeutics Inc.1500 Seaport Boulevard Redwood City, CA 94063US

Dana-Farber Cancer Institute, Inc.450 Brookline Avenue Boston, MA 02215US

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

Afar, Daniel2882 Arlington Place Fremont, California 94555US

Andersen, Kenneth C.264 Weston Road Wellesley, Massachusetts 02482US

Tai, Yu-Tzu22 Olde Filed road Newton, Massachusetts 02459US

Information about Fees